BridgeBio Pharma, Inc. ($BBIO)
Kumar Neil โ Director
Shares
5,960
Price
$72.27
Total Value
$430,751.25
Nearby Earnings
Feb 19, 2026
EPS:Est: -0.74
Revenue:Est: $149.07M
Feb 24, 2026
EPS:Est: -0.75
Revenue:Est: $149.07M
Transaction Details
| Insider | Kumar Neil |
|---|---|
| Title | Director |
| Transaction Date | Feb 10, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Indirect |
| Nature of Ownership | By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 10, 2026 |
| Shares Sold | 5,960 |
| Price per Share | $72.27 |
| Total Value | $430,751.25 |
| Shares Owned After | 4,498,447 |
| Derivative | No |
| Accession Number | 0001470831-26-000118 |
| Document | View SEC Filing |